We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $434M
1-Year Est. Return 9.09%
This Fund
S&P 500
This Quarter Est. Return
+7.24%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$372M
AUM Growth
+$9.67M
Cap. Flow
-$8.59M
Cap. Flow %
-2.31%
Top 10 Hldgs %
39.3%
Holding
62
New
1
Increased
12
Reduced
30
Closed
8

Top Sells

Rank Stock Value
1
EFX icon
Equifax
EFX
+$7.91M
2
RTX icon
RTX Corp
RTX
+$6.84M
3
LHX icon
L3Harris
LHX
+$2.1M
4
MSI icon
Motorola Solutions
MSI
+$2.06M
5
AOS icon
A.O. Smith
AOS
+$1.97M

Sector Composition

Rank Sector Weight
1 Technology 27.42%
2 Healthcare 18.15%
3 Financials 16.07%
4 Consumer Staples 11.71%
5 Consumer Discretionary 10.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROST icon
26
Ross Stores
ROST
$80.5B
$6.34M 1.71%
59,722
+40
+0.1% +$4.49K
GWW icon
27
W.W. Grainger
GWW
$65.3B
$6.21M 1.67%
9,022
-2,466
-21% -$1.57M
KO icon
28
Coca-Cola
KO
$377B
$5.81M 1.56%
93,720
ULTA icon
29
Ulta Beauty
ULTA
$22B
$5.74M 1.54%
10,519
-405
-4% -$208K
PEP icon
30
PepsiCo
PEP
$190B
$5.43M 1.46%
29,801
-602
-2% -$105K
AOS icon
31
A.O. Smith
AOS
$8.17B
$5.35M 1.44%
77,324
-30,247
-28% -$1.97M
BRK.B icon
32
Berkshire Hathaway Class B
BRK.B
$1.1T
$5.04M 1.36%
16,323
OTIS icon
33
Otis Worldwide
OTIS
$27.4B
$4.77M 1.28%
56,567
-1,059
-2% -$87.6K
LHX icon
34
L3Harris
LHX
$51.6B
$4.52M 1.22%
23,046
-10,280
-31% -$2.1M
SEIC icon
35
SEI Investments
SEIC
$12.4B
$4.43M 1.19%
76,911
-1,415
-2% -$84.9K
HUM icon
36
Humana
HUM
$43.7B
$4.43M 1.19%
9,116
-137
-1% -$67.7K
SONY icon
37
Sony
SONY
$137B
$3.62M 0.97%
199,665
-7,450
-4% -$129K
UNP icon
38
Union Pacific
UNP
$174B
$3.56M 0.96%
17,712
+647
+4% +$131K
WTW icon
39
Willis Towers Watson
WTW
$31.2B
$3.09M 0.83%
13,279
-69
-0.5% -$16.7K
WMT icon
40
Walmart Inc
WMT
$885B
$2.94M 0.79%
59,850
NVS icon
41
Novartis
NVS
$297B
$2.7M 0.73%
29,330
-673
-2% -$58.8K
CME icon
42
CME Group
CME
$96.3B
$2.53M 0.68%
13,207
-6,713
-34% -$1.21M
PFE icon
43
Pfizer
PFE
$143B
$2.52M 0.68%
61,720
-18,657
-23% -$806K
SNY icon
44
Sanofi
SNY
$103B
$2.26M 0.61%
41,527
-6,929
-14% -$337K
ABBV icon
45
AbbVie
ABBV
$443B
$1.95M 0.53%
12,242
UL icon
46
Unilever
UL
$137B
$1.28M 0.34%
21,896
-284
-1% -$16.1K
ABT icon
47
Abbott
ABT
$183B
$1.24M 0.33%
12,200
KHC icon
48
Kraft Heinz
KHC
$30.7B
$712K 0.19%
18,418
PG icon
49
Procter & Gamble
PG
$336B
$525K 0.14%
3,532
IMXI icon
50
International Money Express
IMXI
$357M
$398K 0.11%
15,419

Similar funds

Foyston, Gordon, & Payne's Q1 2023 Portfolio in Review

As of Q1 2023, Foyston, Gordon, & Payne held 62 positions worth $372M, up 2.7% from $362M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Foyston, Gordon, & Payne's Q1 2023 filing shows 1 new, 12 increased, 30 reduced and 8 closed positions. The largest sale was Equifax, an estimated $7.91M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Foyston, Gordon, & Payne added most to Alphabet (Google) Class A in Q1 2023, an estimated $3.59M increase.
  • Foyston, Gordon, & Payne's biggest Q1 2023 reduction was L3Harris, cutting an estimated $2.1M.
  • Foyston, Gordon, & Payne fully exited Equifax in Q1 2023, selling an estimated $7.91M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 39% of its $372M portfolio in Q1 2023.
  • Foyston, Gordon, & Payne opened 1 new position and closed 8 in Q1 2023.
  • Foyston, Gordon, & Payne's portfolio value rose 2.7% quarter-over-quarter to $372M.

Based on Foyston, Gordon, & Payne's 13F filing for Q1 2023, filed 3 May 2023.